Skip Navigation


JAC Advance Access originally published online on April 14, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/5/1307    most recent
dkg232v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rubinstein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubinstein, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 1307-1308
© 2003 The British Society for Antimicrobial Chemotherapy

Correspondence

Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones

Ethan Rubinstein*

Infectious Diseases Unit, Sheba Medical Center, Tel Aviv University Faculty of Medicine, Tel Hashomer 52621, Israel

Keywords: levofloxacin, Streptococcus pneumoniae, pneumonia, model

The first 10% of the full text of this article appears below.

Sir,

Croisier et al.1 described an experimental model of pneumococcal pneumonia in the rabbit caused by penicillin-resistant Streptococcus pneumoniae with different susceptibilities to fluoroquinolones. In this model, levofloxacin, at a dose that simulated human treatment with 500 mg twice a day, was effective against strains with levofloxacin MIC < 1.5 mg/L, but ineffective against strains . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
D. Croisier, M. Etienne, and P. Chavanet
Reply
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1308 - 1309.
[Full Text] [PDF]